DE69825051T2 - Schwefel-überführungs-reagenz für oligonukleotid-synthese - Google Patents

Schwefel-überführungs-reagenz für oligonukleotid-synthese Download PDF

Info

Publication number
DE69825051T2
DE69825051T2 DE69825051T DE69825051T DE69825051T2 DE 69825051 T2 DE69825051 T2 DE 69825051T2 DE 69825051 T DE69825051 T DE 69825051T DE 69825051 T DE69825051 T DE 69825051T DE 69825051 T2 DE69825051 T2 DE 69825051T2
Authority
DE
Germany
Prior art keywords
amino
thione
dithiazole
organic group
sulfur transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69825051T
Other languages
German (de)
English (en)
Other versions
DE69825051D1 (de
Inventor
Han Yongxin
Jimmy Tang
Zhoada Zhang
Jin-Yan Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Avecia Inc
Original Assignee
Avecia Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avecia Biotechnology Inc filed Critical Avecia Biotechnology Inc
Publication of DE69825051D1 publication Critical patent/DE69825051D1/de
Application granted granted Critical
Publication of DE69825051T2 publication Critical patent/DE69825051T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69825051T 1997-05-30 1998-05-26 Schwefel-überführungs-reagenz für oligonukleotid-synthese Expired - Lifetime DE69825051T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US865666 1997-05-30
US08/865,666 US6096881A (en) 1997-05-30 1997-05-30 Sulfur transfer reagents for oligonucleotide synthesis
PCT/US1998/010653 WO1998054198A1 (en) 1997-05-30 1998-05-26 Novel sulfur transfer reagents for oligonucleotide synthesis

Publications (2)

Publication Number Publication Date
DE69825051D1 DE69825051D1 (de) 2004-08-19
DE69825051T2 true DE69825051T2 (de) 2005-10-06

Family

ID=25345990

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825051T Expired - Lifetime DE69825051T2 (de) 1997-05-30 1998-05-26 Schwefel-überführungs-reagenz für oligonukleotid-synthese

Country Status (9)

Country Link
US (1) US6096881A (enExample)
EP (1) EP0986571B1 (enExample)
JP (1) JP4393594B2 (enExample)
AT (1) ATE271065T1 (enExample)
AU (1) AU7597498A (enExample)
CA (1) CA2291688C (enExample)
DE (1) DE69825051T2 (enExample)
ES (1) ES2226135T3 (enExample)
WO (1) WO1998054198A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7098325B2 (en) * 1998-10-08 2006-08-29 Pierre Martin Process for the sulfurization of a phosphorus-containing compound
DE69910140T2 (de) * 1998-10-08 2004-06-03 Novartis Ag Verfahren zur Sulfurierung von Phosphor-enthaltenden Verbindungen
GB0004889D0 (en) 2000-03-01 2000-04-19 Avecia Ltd Synthesis of oligonucleotides
EP1343802B1 (en) * 2000-12-05 2012-05-30 Avecia Biotechnology Inc Process for the preparation of oligonucleotides
US6768005B2 (en) * 2000-12-20 2004-07-27 Avecia Limited Process
AR036122A1 (es) * 2001-07-03 2004-08-11 Avecia Biotechnology Inc Un complejo de sal que comprende un n-alquilimidazol y una 1,1-dioxo-1,2-dihidro-1l6-benzo [d]-isotiazol-3-ona y un metodo para sintetizar oligonucleotidos utilizando la quimica de fosforamidita
JP4825375B2 (ja) * 2001-08-28 2011-11-30 株式会社 資生堂 ジチアゾール化合物及びマトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤
GB0209539D0 (en) * 2002-04-26 2002-06-05 Avecia Ltd Monomer Polymer and process
CA2561741C (en) * 2004-04-05 2016-09-27 Alnylam Pharmaceuticals, Inc. Processes and reagents for oligonucleotide synthesis and purification
CN104086516B (zh) * 2014-07-18 2016-01-06 成都樵枫科技发展有限公司 R-(+)-硫代四氢呋喃-2-甲酸的合成方法
KR20190100225A (ko) 2016-12-28 2019-08-28 다이이찌 산쿄 가부시키가이샤 알포트 증후군 치료약
WO2019111791A1 (ja) * 2017-12-07 2019-06-13 第一三共株式会社 ジストロフィン遺伝子のイントロンリテンションを解消するアンチセンスオリゴヌクレオチド
CN115976028B (zh) 2018-03-09 2025-03-25 第一三共株式会社 糖原病Ia型治疗药
US20210207136A1 (en) 2018-06-13 2021-07-08 Daiichi Sankyo Company, Limited Myocardial dysfunction therapeutic agent
WO2020246560A1 (ja) 2019-06-05 2020-12-10 学校法人福岡大学 化学修飾核酸を導入した安定型標的編集ガイドｒｎａ
JP7715345B2 (ja) 2019-06-26 2025-07-30 神戸天然物化学株式会社 ミオスタチン遺伝子のｍＲＮＡの産生を抑制する核酸医薬
US20220364086A1 (en) 2019-07-12 2022-11-17 Daiichi Sankyo Company, Limited ANTISENSE OLIGONUCLEOTIDE CAPABLE OF ALTERING SPLICING OF DUX4 pre-mRNA
CA3150715A1 (en) 2019-09-10 2021-03-18 Makoto Koizumi Conjugate of galnac-oligonucleotide for delivery to liver and manufacturing method thereof
TW202128704A (zh) 2019-10-18 2021-08-01 日商第一三共股份有限公司 雙環亞磷醯胺之製造方法
EP4119167A4 (en) 2020-03-11 2025-08-06 Biocomber Co Ltd SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR INDUCING FRAME SHIFT-1 AND COMPOSITION
US20230272403A1 (en) 2020-07-28 2023-08-31 Knc Laboratories Co., Ltd. Antisense oligonucleotide inducing exon skipping of angiotensin converting enzyme 2 gene
WO2022124345A1 (ja) 2020-12-08 2022-06-16 学校法人福岡大学 化学修飾核酸を導入した安定型標的編集ガイドｒｎａ
CA3211057A1 (en) 2021-02-26 2022-09-01 Knc Laboratories Co., Ltd. Nucleic acid medicine expressing splicing variant of myostatin
CN118891366A (zh) 2022-03-16 2024-11-01 第一三共株式会社 抑制转铁蛋白受体2的表达的siRNA
CN118871585A (zh) 2022-03-16 2024-10-29 第一三共株式会社 具有RNAi活性的化学-修饰的寡核苷酸

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753908A (en) * 1971-08-30 1973-08-21 Chevron Res Oxidation inhibited lubricating oil compositions with extreme pressure properties
DE4320157A1 (de) * 1993-06-18 1994-12-22 Bayer Ag Verwendung von 1,2,4-Dithiazolium-Salzen als Chemotherapeutica

Also Published As

Publication number Publication date
CA2291688C (en) 2008-01-29
DE69825051D1 (de) 2004-08-19
CA2291688A1 (en) 1998-12-03
JP2002501534A (ja) 2002-01-15
JP4393594B2 (ja) 2010-01-06
WO1998054198A1 (en) 1998-12-03
AU7597498A (en) 1998-12-30
EP0986571B1 (en) 2004-07-14
ES2226135T3 (es) 2005-03-16
WO1998054198A9 (en) 1999-04-01
ATE271065T1 (de) 2004-07-15
US6096881A (en) 2000-08-01
EP0986571A1 (en) 2000-03-22

Similar Documents

Publication Publication Date Title
DE69825051T2 (de) Schwefel-überführungs-reagenz für oligonukleotid-synthese
DE69030745T2 (de) Verfahren und Reagens zur Sulfurierung von Organophosphiten
DE69319336T2 (de) N-acylierte 2'-deoxycytidine für die oligonukleotid synthese
DE69129269T2 (de) Verfahren zur herstellung von oligonukleotid-analogen die schwefel enthalten
DE69937439T3 (de) Verbesserter Entschützungsmethode für die Synthese von Oligomerverbindungen
EP0152459B1 (de) Verfahren zur herstellung von oligonucleotiden
DE3689715T2 (de) Verfahren und Reagenzien für die In-vitro-Synthese von Oligonukleotiden.
DE69026963T2 (de) Verfahren zur herstellung von oligonucleotiden, anwendbar zu serienherstellung
DE69429338T2 (de) Nicht-nucleosidische cumarin-derivate als reagenzien zum crosslinking von polynucleotiden
DE69609184T2 (de) Verfahren zur synthese von oligonukleotiden
DE69724218T2 (de) Universale feste träger und verfahren zu ihrer verwendung
EP0679657A2 (de) Nukleoside und Oligonukleotide mit 2'-Ethergruppen
DE69828076T3 (de) Synthese von sulfurierten oligonukleotiden
EP0563010A2 (de) Verfahren zur Herstellung von Nukleosiden
DE69609511T2 (de) Neue Synthons für die stereoselektive Oligonuklodsynthese
DE60209128T2 (de) Aktivatoren für die oligonukleotidsynthese
EP0195277B1 (de) Verfahren und Mittel zur Phosphorylierung
DE60103145T2 (de) Verfahren zur herstellung von phoshphorothioate triestere
DE69724768T2 (de) Oligonukleotid-analoge
DE69405396T2 (de) Verfahren zur synthese von nukleinsäuren auf einem festträger und verbindungen verwendbar als festträger in diesem verfahren
DE69718244T2 (de) Chemische Phosphorylierung von Oligonukleotiden und Reagenz dafür
DE19627898A1 (de) Festphasensynthese von Oligonucleotiden
DE69400807T2 (de) Bausteine mit carbamate luternukleosidverbindungen und oligonukleotide abgeleitet davon
DE2505297B2 (de) Verfahren zur Herstellung von in 2- und 6-Stellung des Phenylkerns substituierten 2-Phenylamino-2-imidazolin-Derivaten
DE60109047T2 (de) Synthone zur herstellung von oligonukleotiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition